The Clearfield-Jefferson Drug and Alcohol Commission recognized the increase in opiate abuse in our counties and in response, developed a Medication Assisted Treatment (MAT) model based on the needs and concerns of our community.
MAT is the use of medications, in combination with counseling and behavioral therapies, to provide a whole-patient approach to the treatment of substance use disorders. Research shows that when treating substance use disorders, a combination of medication and behavioral therapies is most successful.
Buprenorphine has been approved by the FDA since 2002 for detoxification of opioid dependence and maintenance therapy. By giving the patient options for their treatment of opiate addiction, it empowers the patient to be motivated and become more involved in their care.
The MAT program consists of the buprenorphine coordinator, physician, treatment provider, pharmacist, and any other provider who is working with the client in assisting him/her with their recovery. Each party works collaboratively to provide a structured recovery oriented system of care that will assist the client on their journey to sobriety.